Pittsford, NY, United States of America

Angelica Moksa



Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Angelica Moksa: Innovator in Immunoglobulin Research**

Introduction

Angelica Moksa is an accomplished inventor located in Pittsford, NY, who has significantly contributed to the field of immunology. With a total of two patents, her innovative work focuses on enhancing the methods for producing and selecting immunoglobulin molecules, which are vital in therapeutic applications.

Latest Patents

Angelica Moksa's most recent patents revolve around advanced techniques for expressing immunoglobulin molecules in eukaryotic cells. The first patent, titled "Fusion proteins to facilitate selection of cells infected with specific immunoglobulin gene recombinant vaccinia virus," details a high-efficiency method for expressing immunoglobulin heavy and light chain libraries using the trimolecular recombination technique. This invention also introduces methods for selecting and screening antigen-specific immunoglobulin molecules, as well as providing kits for the production and selection of these critical molecules. Her second patent, "Method for selecting polynucleotides encoding antigen-specific immunoglobulin subunits," echoes this innovative approach, further emphasizing the importance of streamlining the production and selection of immunoglobulin molecules and their fragments.

Career Highlights

Angelica Moksa is currently an essential member of Vaccinex, Inc., where she applies her expertise to advance immunological research. Her focus on efficient methodologies for immunoglobulin expression significantly impacts the field, facilitating the development of new therapeutic strategies.

Collaborations

Throughout her career, Moksa has worked alongside notable colleagues such as Ernest S. Smith and Tracy Pandina. Their collaboration at Vaccinex, Inc. aids in pushing the boundaries of immunoglobulin research and expands the potential for innovative therapies derived from her patented methodologies.

Conclusion

Angelica Moksa's contributions to the field of immunology are noteworthy, with her patents reflecting her dedication to innovation in the production of immunoglobulin molecules. As a key figure at Vaccinex, Inc., she continues to advance scientific knowledge and technological development, making significant strides in therapeutic applications that may benefit countless patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…